A detailed history of Schnieders Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Schnieders Capital Management LLC holds 52,728 shares of ABT stock, worth $5.36 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
52,728
Previous 52,778 0.09%
Holding current value
$5.36 Million
Previous $5.81 Million 3.17%
% of portfolio
1.25%
Previous 1.3%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$109.52 - $120.96 $5,476 - $6,048
-50 Reduced 0.09%
52,728 $5.99 Million
Q4 2023

Feb 01, 2024

SELL
$90.19 - $110.4 $1.6 Million - $1.96 Million
-17,738 Reduced 25.15%
52,778 $5.81 Million
Q3 2023

Nov 07, 2023

SELL
$95.53 - $114.62 $1.59 Million - $1.91 Million
-16,652 Reduced 19.1%
70,516 $6.83 Million
Q2 2023

Aug 01, 2023

SELL
$100.78 - $112.29 $43,940 - $48,958
-436 Reduced 0.5%
87,168 $9.5 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $77,488 - $91,208
800 Added 0.92%
87,604 $8.87 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $413,606 - $485,223
4,351 Added 5.28%
86,804 $9.53 Million
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $1.05 Million - $1.21 Million
10,839 Added 15.14%
82,453 $7.98 Million
Q2 2022

Jul 28, 2022

SELL
$102.07 - $123.37 $122,892 - $148,537
-1,204 Reduced 1.65%
71,614 $7.78 Million
Q1 2022

Apr 27, 2022

SELL
$114.02 - $139.04 $58,720 - $71,605
-515 Reduced 0.7%
72,818 $8.62 Million
Q4 2021

Feb 03, 2022

BUY
$115.53 - $141.46 $149,264 - $182,766
1,292 Added 1.79%
73,333 $10.3 Million
Q3 2021

Nov 01, 2021

SELL
$116.66 - $129.06 $29,748 - $32,910
-255 Reduced 0.35%
72,041 $8.51 Million
Q2 2021

Aug 10, 2021

BUY
$105.79 - $124.53 $6,770 - $7,969
64 Added 0.09%
72,296 $8.38 Million
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $58,773 - $69,244
540 Added 0.75%
72,232 $8.66 Million
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $24,675 - $26,888
235 Added 0.33%
71,692 $7.85 Million
Q3 2020

Nov 05, 2020

SELL
$91.64 - $111.29 $34,090 - $41,399
-372 Reduced 0.52%
71,457 $7.78 Million
Q2 2020

Aug 07, 2020

BUY
$76.57 - $98.0 $1,914 - $2,450
25 Added 0.03%
71,829 $6.57 Million
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $18,092 - $26,455
288 Added 0.4%
71,804 $5.67 Million
Q4 2019

Feb 07, 2020

BUY
$78.51 - $87.4 $151,916 - $169,119
1,935 Added 2.78%
71,516 $6.21 Million
Q3 2019

Nov 07, 2019

BUY
$81.84 - $88.74 $33,718 - $36,560
412 Added 0.6%
69,581 $5.82 Million
Q2 2019

Aug 07, 2019

SELL
$72.88 - $85.0 $8,526 - $9,945
-117 Reduced 0.17%
69,169 $5.82 Million
Q1 2019

May 03, 2019

SELL
$66.22 - $80.06 $54,631 - $66,049
-825 Reduced 1.18%
69,286 $5.54 Million
Q4 2018

Feb 01, 2019

SELL
$65.56 - $74.27 $34,419 - $38,991
-525 Reduced 0.74%
70,111 $5.07 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $9,121 - $11,004
150 Added 0.21%
70,636 $5.18 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $28,209 - $31,134
-490 Reduced 0.69%
70,486 $4.3 Million
Q1 2018

May 10, 2018

SELL
$56.27 - $63.62 $13,392 - $15,141
-238 Reduced 0.33%
70,976 $4.25 Million
Q4 2017

Feb 08, 2018

BUY
$53.68 - $57.47 $10,736 - $11,494
200 Added 0.28%
71,214 $4.06 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $3.41 Million - $3.81 Million
71,014
71,014 $3.79 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $178B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Schnieders Capital Management LLC Portfolio

Follow Schnieders Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schnieders Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schnieders Capital Management LLC with notifications on news.